The Brighterside of News on MSN
New drug combo cuts risk of death for men with prostate cancer by 40%
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...
Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...
WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...
A bandaged head — later confirmed to be evidence of a recent cancer surgery — has added to concerns about former President ...
Health and Me on MSN
This FDA-Approved Drug Combo Could Reduce Risk Of Prostate Cancer Deaths By 40%
Researchers have been working on ways to improve prostate cancer diagnosis and deaths for years. Being one of the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback